MAIA Biotechnology Announces First Patient Dosed in Expansion of Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical ...

Milestone marks a key advancement in the partnership with Ipsen. MONTRÉAL , July 8, 2025 /PRNewswire/ - IRIC and IRICoR today announced the start of a Phase 1 clinical trial of its small molecule ...

Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD (L)-1 therapy: an open-label, ...

mMR is associated with better treatment response than gepants in patients with migraine who previously had an inadequate response to gepants.

Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after receiving an advanced stem cell therapy.

Erratum: Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor–Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic ...

Pfizer's hemophilia therapy, Hympavzi, met the main goal of a late-stage study in patients with certain types of antibodies, the U.S. drugmaker said on Thursday.

U.S. President Donald Trump has called for Israel to pardon Prime Minister Benjamin Netanyahu or cancel his corruption trial, saying the U.S. would save him like it did his country.

The 14-gene assay identified patients with molecular high risk who benefitted from adjuvant chemotherapy. Use of the assay to determine eligibility for adjuvant therapy in stage IA–IIA non-squamous ...